ICON Public (ICLR) Stock Forecast & Price Target

$323.46

+10.36 (+3.31%)

(As of 07/26/2024 ET)

ICON Public - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 10 Analyst Ratings

Based on 10 Wall Street analysts who have issued ratings for ICON Public in the last 12 months, the stock has a consensus rating of "Buy." Out of the 10 analysts, 10 have given a buy rating for ICLR.

Consensus Price Target

$352.56
9.00% Upside

High Forecast	$383.00
Average Forecast	$352.56
Low Forecast	$315.00

According to the 10 analysts' twelve-month price targets for ICON Public, the average price target is $352.56. The highest price target for ICLR is $383.00, while the lowest price target for ICLR is $315.00. The average price target represents a forecasted upside of 9.00% from the current price of $323.46.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Buy	Buy	Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	10 Buy rating(s)	10 Buy rating(s)	8 Buy rating(s)	7 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$352.56	$345.30	$321.64	$264.70
Forecasted Upside	9.00% Upside	12.91% Upside	11.96% Upside	22.84% Upside

Get ICON Public Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ICLR and its competitors with MarketBeat's FREE daily newsletter.

Ad Crypto 101 Media

Next opportunity for crypto millions

The Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…

Check out the new "Crypto Bull Run Millionaire Blueprint" now!

ICLR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ICLR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

ICON Public Stock vs. The Competition

Type	ICON Public	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.72	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	9.00% Upside	3,123.18% Upside	9.15% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
7/26/2024	Barclays 2 of 5 stars	Lower Target	Overweight ➝ Overweight	$355.00 ➝ $350.00	+9.91%
7/26/2024	Truist Financial 1 of 5 stars	Boost Target	Buy ➝ Buy	$367.00 ➝ $383.00	+22.33%
7/8/2024	Robert W. Baird 2 of 5 stars	Boost Target	Outperform ➝ Outperform	$367.00 ➝ $376.00	+18.01%
6/6/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$370.00	+12.24%
5/31/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
5/31/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$349.00 ➝ $373.00	+15.09%
Get the Latest News and Ratings for ICLR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ICON Public and its competitors with MarketBeat's FREE daily newsletter.
4/26/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$350.00 ➝ $330.00	+6.90%
4/4/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$346.00	+7.76%
12/20/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$295.00 ➝ $330.00	+18.21%
12/11/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$300.00 ➝ $315.00	+15.61%
7/14/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$280.00 ➝ $300.00	+21.55%
5/1/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		$245.00 ➝ $220.00	+14.17%
4/28/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		$271.00 ➝ $263.00	+37.91%
11/9/2022	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$265.00 ➝ $260.00	+33.29%
9/7/2022	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$270.00	+29.34%
8/24/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$260.00	+14.37%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:37 AM ET.

ICLR Forecast - Frequently Asked Questions

What is ICON Public's forecast for 2024?: According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for ICON Public is $352.56, with a high forecast of $383.00 and a low forecast of $315.00.
Should I buy or sell ICON Public stock right now?: 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICON Public in the last twelve months. There are currently 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ICLR shares.
Does ICON Public's stock price have much upside?: According to analysts, ICON Public's stock has a predicted upside of 13.92% based on their 12-month stock forecasts.
What analysts cover ICON Public?: ICON Public has been rated by research analysts at Barclays, Robert W. Baird, TD Cowen, The Goldman Sachs Group, Truist Financial, and William Blair in the past 90 days.
Do Wall Street analysts like ICON Public more than its competitors?: Analysts like ICON Public more than other "medical" companies. The consensus rating for ICON Public is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ICLR compares to other companies.